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Trypanosoma cruzi is the etiologic agent of Chagas’ disease, which affects 6–7 million
people worldwide. Different strains of T. cruzi present specific genotypic and phenotypic
characteristics that affect the host–pathogen interactions, and thus, the parasite has
been classified into six groups (TcI to TcVI). T. cruzi infection presents two clinical phases,
acute and chronic, both with distinct characteristics and important participation by the
immune system. However, the specific contributions of parasite and host factors in the
disease phases are not yet fully understood. The murine model for Chagas’ disease is
well-established and reproduces important features of the human infection, providing
an experimental basis for the study of host lineages and parasite strains. Thus, we
evaluated acute and chronic infection by the G (TcI) and CL (TcVI) strains of T. cruzi,
which have distinct tropisms and infectivity, in two inbred mice lineages (C57BL/6
and BALB/c) that display variable degrees of susceptibility to different T. cruzi strains.
Analysis of the parasite loads in host tissues by qPCR showed that CL strain established
an infection faster than the G strain; at the same time, the response in BALB/c mice,
although diverse in terms of cytokine secretion, was initiated earlier than that in C57BL/6
mice. At the parasitemia peak in the acute phase, we observed, either by confocal
microscopy or by qPCR, that the infection was disseminated in all groups analyzed,
with some differences concerning parasite tropism; at this point, all animals responded
to infection by increasing the serum concentrations of cytokines. However, BALB/c
mice seemed to better regulate the immune response than C57BL/6 mice. Indeed, in
the chronic phase, C57BL/6 mice still presented exacerbated cytokine and chemokine
responses. In summary, our results indicate that in these experimental models, the
deregulation of immune response that is typical of chronic Chagas’ disease may be
due to control loss over pro- and anti-inflammatory cytokines early in the acute phase of
the disease, depending primarily on the host background rather than the parasite strain.
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INTRODUCTION
Trypanosoma cruzi (T. cruzi), a flagellate protozoan, is the
etiological agent of Chagas’ disease. Approximately 6–7 million
people are infected worldwide, mostly in Latin America, although
the incidence has increased on other continents (WHO, 2017). In
Brazil, Chagas’ disease caused 76% of the deaths due to neglected
tropical diseases between 2000 and 2011 (Martins-Melo et al.,
2016).
The progression and severity of Chagas’ disease vary according
to individual and geographic region and also depend on parasite
tissue tropism (Melo and Brener, 1978). These differences may
rely on genotypic and phenotypic characteristics, particular for
each T. cruzi isolate, interfering in host–parasite interaction.
T. cruzi strains are distributed into six distinct groups (TcI to
TcVI) based on the identification of six discrete typing units
(DTUs) (Zingales et al., 2009).
Chagas’ disease has two clinical phases, acute and chronic.
The acute phase lasts approximately 2 months and is usually
asymptomatic or presents non-specific symptoms. In the chronic
phase, patients may not experience symptoms for decades, but
nearly 30% suffer from cardiomyopathy, dysfunction in the
digestive tract (megaesophagus/megacolon) or alterations in the
nervous system (Taniwaki et al., 2005; Rassi et al., 2010; WHO,
2017). However, controversies regarding the causes of disease
manifestations in the chronic phase can be found in the literature
(Nagajyothi et al., 2012). There are two main hypotheses. The first
hypothesis supposes that tissue damage is primarily caused by
an autoimmune response due to the molecular mimicry of host
antigens by the parasite, while the second hypothesis proposed
that parasite persistence in host tissues causes inflammatory
responses that lead to tissue damage (Gutierrez et al., 2009;
Cunha-Neto et al., 2011).
Involvement of immune system is essential in both phases
of Chagas’ disease. In the acute phase, a vigorous immune
response suppresses parasitemia and parasite spread; in the
chronic phase, however, different response profiles are related
to the asymptomatic form or the manifestation of chronic
symptoms (reviewed in Boscardin et al., 2010; Basso, 2013).
Several aspects of the immune response are regulated by
cytokines, a heterogeneous group of soluble proteins synthesized
by distinct cell types, and by chemokines, a group of cytokines
responsible for cell recruitment. Although the activity of
cytokines usually remains restricted to their production site,
when large amounts are synthetized, they can be released into
the bloodstream and present endocrine activity (Clark-Lewis
et al., 1995; Dinarello, 2007). In chronic Chagas’ disease, plasma
cytokines are apparently related to disease severity, either with
clinical symptoms or in indeterminate phase (Sousa et al., 2014).
Different cytokine expression profiles have also been related to
the susceptibility to Chagas disease in the acute phase (Roggero
et al., 2002). Similarly, chemokines participate in the immune
response and the development of Chagas’ pathology (Aliberti
et al., 1999; Cunha-Neto et al., 2009).
The murine experimental model reproduces human Chagas’
disease in many ways. For instance, mice immune response and
the cytokine expression levels in the acute and chronic phases
are similar to human disease. BALB/c and C57BL/6 inbred mice
present different degrees of susceptibility and different resistance
patterns depending on the T. cruzi strain. It is known that CL
strain (TcVI) is highly infective in both C57BL/6 and BALB/c
mice and in cell cultures (Gonçalves da Costa et al., 2002);
on the other hand, the G strain (TcI) is less infective in cell
cultures and might generate undetectable parasitemia levels in
mice (Yoshida, 1983; Rodrigues et al., 2012). Thus BALB/c and
C57BL/6 inbred mice infected with T. cruzi CL and G strains
were used to evaluate aspects of Chagas’ disease in the acute
and chronic phases, considering that the heterogeneity of the
disease clinical course results from the interaction of parasite
and host factors (Girones and Fresno, 2003; Dutra et al., 2009).
In each group, the parasite load in host tissues was analyzed at
different time-points by qPCR, the spread of the parasite was
imaged by confocal microscopy, and serum levels of cytokines
were measured. The results obtained in this study suggest that
although there are differences in T. cruzi tropism according to
parasite strains, the immune responses along the infection course
depend primarily on the host background.
MATERIALS AND METHODS
Ethics Statement
All animal procedures used in this study were approved
by the Committee on Ethics of Animal Experiments of the
Universidade Federal de São Paulo (CEUA/UNIFESP – number
33710910/14). The experiments were conducted under the
Brazilian National Committee on Ethics Research (CONEP)
ethical guidelines, which are in accordance with international
standards (CIOMS/OMS, 1985).
Parasites
We used G (TcI) (Yoshida, 1983) and CL (TcVI) (Brener
and Chiari, 1963) T. cruzi strains, wild-type or transfected
with GFP (G strain) (Cruz et al., 2012) or DsRed (CL strain)
(Ferreira et al., 2016) in pTREX plasmids. Tissue-culture
derived trypomastigotes (TCTs), analogous to bloodstream
trypomastigotes, were obtained from the supernatant of infected
Vero cells (Instituto Adolfo Lutz, São Paulo, SP, Brazil) that
were grown in RPMI 1640 medium (Vitrocell, Embriolife,
Brazil) supplemented with 2% fetal bovine serum (FBS) (Gibco,
Thermo Fisher Scientific, United States), 10µg/mL streptomycin,
100 U/mL penicillin and 40 µg/mL gentamicin (antibiotics from
Sigma-Aldrich, United States) at 37◦C and 5% CO2.
Mice and T. cruzi Infection
BALB/c and C57BL/6 female mice ranging from 6 to 8 weeks old
were infected intraperitoneally with 106 TCTs in 0.5 ml PBS; the
control animals were injected with a PBS solution prepared after
centrifugation of the supernatant of Vero cells. Parasitemia was
monitored as described by Brener (1962) in both BALB/c and
C57BL/6 mice using the CL strain as a reference, since the G
strain did not present detectable parasitemia levels. Three time
points were then determined for animal euthanasia: 2 days post
infection (dpi), at the beginning of infection; 8 dpi, at the peak
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of parasitemia in the acute phase; and 90 dpi, during the chronic
infection.
DNA Extraction and Quantitative
Real-Time PCR
Primers for a repetitive sequence of T. cruzi DNA (TCZ-F
5′-GCTCTTGCCCACAMGGGTGC-3′, M = A or C and TCZ-R
5′-CCAAGCAGCGGATAGTTCAGG-3′), which amplify a
182-bp sequence, and primers for murine TNF (TNF-5241 5′-TC
CCTCTCATCAGTTCTATGGCCCA-3′ e TNF-5411 5′-CAGCA
AGCATCTATGCACTTAGACCCC-3′), which amplify a
170-bp sequence, were synthesized, as previously described for
T. cruzi tissue quantification (Cummings and Tarleton, 2003).
BALB/c and C57BL/6 mice infected with T. cruzi G or CL
strains were euthanized and the hearts, livers, intestines and
spleens were removed, sectioned and immediately subjected
to DNA extraction using the DNeasy R© Blood & Tissue Kit
(Qiagen, Germany), according to manufacturer’s instructions.
The reactions were performed with 20 ng of genomic DNA,
10 µL of SYBR R© Select Master Mix (Applied Biosystems,
United States) and 0.35 µM each forward and reverse primer in
the StepOnePlus System (Applied Biosystems, United States).
Each plate contained a standard curve and two negative controls,
a control with no template and an uninfected tissue control. The
samples were quantified in duplicate, and data were normalized
by the TNF gene quantity in each sample (Cummings and
Tarleton, 2003).
The standards for the PCR reactions were generated by adding
106 T. cruzi epimastigotes to 20 mg of tissue extracted from
uninfected mice. After DNA extraction, the material was 10-fold
serially diluted with 20 µg/ml uninfected tissue DNA. A standard
curve was then generated from 0.1 to 10000 parasite equivalents
per 20 ng of total DNA, as previously described (Cummings and
Tarleton, 2003).
Tissue Imaging
The spleens, livers, intestines, and hearts were removed from
mice infected with G-GFP or CL-DsRed fluorescent parasites.
The organs were placed onto a cold paraffin surface, and slices
were cut with two parallel GEM single-edge blades, immersed in
PBS containing 1 µM Hoechst 33342 (Invitrogen, Carlsbad, CA,
United States) to label nuclei and then transferred to glass-bottom
dishes (MatTek Corporation, Ashland, MA, United States) in
RPMI-1640 medium (Vitrocell, Embriolife, Brazil) supplemented
with 10% FBS (Gibco, Thermo Fisher Scientific, United States).
Ex vivo specimens were transferred to a stage-top incubator at
37◦C and 5% CO2 with controlled humidity (Tokai Hit, Japan)
on a Leica SP5 TS confocal microscope and imaged with a 63
× NA 1.40 oil-immersion objective using the resonant scanner
(8000 Hz) mode, as described (Ferreira et al., 2016). Final imaging
processing was performed using Imaris software 7.0 (Bitplane).
Quantitation of Serum Cytokines and
Chemokines
Whole blood was obtained by cardiac puncture in infected and
control mice and was collected into tubes containing protease
FIGURE 1 | Parasite-equivalents in murine tissues quantified by qPCR.
BALB/c and C57BL/6 mice infected with G or CL strains were euthanized at 2
(A), 8 (B), or 90 dpi (C). Genomic DNA was then extracted from the hearts,
intestines, livers, and spleens for quantification of parasite-equivalents by
qPCR. Comparisons were made between organs separately. + indicates a
statistically significant difference between parasite strains in infected mice
from a single lineage, ◦ indicates a statistically significant difference between
mice lineages when infected with the same parasite strain. Both + and
◦ indicate p < 0.05. ND, not detected.
inhibitors, including 10 mM EDTA (Thermo Fisher Scientific,
United States), 9 µM aprotinin (Sigma-Aldrich, United States)
and 10 µM E-64 (Sigma-Aldrich, United States). The tubes were
then centrifuged at 3400 g for 5 min at 4◦C, and each serum
sample was separated into two 110-µL aliquots, quick frozen
in liquid nitrogen and stored at −80◦C. These samples were
used to quantify the levels of chemokines and cytokines using
the following kits according to the manufacturer’s instructions:
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FIGURE 2 | Trypanosoma cruzi distributed in murine organs in the acute phase. Hearts, spleens, livers, and intestines of BALB/c and C57BL/6 mice infected with
G-GFP (green) were sectioned, incubated with Hoechst to label the nuclei (blue) and maintained ex vivo in dishes with culture medium for imaging by confocal
microscopy. Parasite nests were found in all analyzed organs at 8 dpi. Bars = 5 µm.
FIGURE 3 | Cytokines with altered serum levels in infected mice at 2 dpi. Serum samples were obtained from C57BL/6 and BALB/c mice uninfected or infected with
G or CL strains at 2 dpi for the quantification of cytokines levels. Box plots correspond to the concentrations of IL-1α (A), IL-5 (B), TGF-β (C), IL-9 (D), and INF-γ (E),
which were different in some groups from the control mice at this time point. ∗ indicates a significant difference (p < 0.05) between infected and uninfected mice
[control (–)].
MILLIPLEX R©MAP Mouse Cytokine/Chemokine Magnetic Bead
Panel (Merck Millipore, Germany) for TNF-α, INF-γ, IL-2, IL-1α,
IL-1β, IL-9, IL-17, IL-6, IL-5, IL-4, IL-10, KC (CXCL1), MIG
(CXCL9), IP10 (CXCL10), MCP-1 (CCL2), MIP-1α (CCL3),
MIP-1β (CCL4), RANTES (CCL5), and Eotaxin (CCL11)
quantitation and MILLIPLEX R©MAP TGF-β1, 2, 3 Magnetic Bead
Kit (Merck Millipore, Germany) for TGF-β1 quantitation in the
MAGPIX R© system (Merck Millipore, Germany). All samples were
analyzed in duplicate.
Statistical Analysis
The experiments were performed with three mice per group, and
the results are presented as the mean ± standard deviation or a
box plot. The differences were considered statistically significant
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FIGURE 4 | Th1 cytokine levels altered in infected mice sera at 8 dpi. The concentrations of TNF-α (A), INF-γ (B), IL-1β (C), and IL-2 (D) cytokines in serum samples
from C57BL/6 and BALB/c mice infected with G or CL strains differed from those in the serum samples of control mice at 8 dpi. The data are presented as box
plots, and ∗ indicates a significant difference (p < 0.05) between the infected and uninfected mice [control (–)].
when p < 0.05 by one-way (cytokines quantitation) or two-way
(qPCR) ANOVA followed by Bonferroni multiple comparisons
test in Prism 6.0 software (GraphPad, United States).
RESULTS
Parasite Loads in Mouse Organs Depend
on T. cruzi Strain
Parasite loads were quantified in the spleens, hearts, livers, and
intestines from BALB/c and C57BL/6 mice at each infection time-
point. The parasites were initially found in both mice infected
with CL strain at 2 dpi. At this time point parasites were detected
in all analyzed organs from CL-strain infected BALB/c mice. In
C57BL/6 mice infected with CL, the livers and spleens held the
largest quantity of parasites, while few parasites were found in the
hearts. However, in animals infected with G strain, parasites were
detected in much lower amounts than were observed in those
infected with CL strain (Figure 1A).
At 8 dpi, parasites were detected mainly in the livers and
spleens of all infected mice, except in BALB/c infected with G
strain, in which the quantity of parasites in the spleen was lower.
Additionally, in this group there were many parasites in the heart
and intestine. On the other hand, BALB/c mice infected with
the CL strain showed a high parasite load in the spleen, liver,
and heart, but not in intestine. In C57BL/6 mice infected with
G strain, the numbers of parasites in the spleen and liver were
lower than in those infected with CL strain (Figure 1B). Overall,
in the acute phase, parasites were distributed in different organs
of all mice. Similar results were observed by confocal microscopy
in live tissues extracted from mice infected with G strain-GFP,
where parasite nests were found in all analyzed tissues (Figure 2).
The same procedure were performed in CL-DsRed infected mice,
but due to weak fluorescence we could not obtain representative
images. Nonetheless, images of CL-DsRed infected tissues (mice)
can be found in our previous work (Ferreira et al., 2016).
At 90 dpi, (chronic phase) T. cruzi detection was clearly lower
than at previous infection time points, and all mice succeeded
in controlling parasitemia, since parasite loads were not higher
than 1 parasite equivalent per 20 ng of total DNA in all tissues.
In BALB/c mice infected with G strain, parasites were especially
found in the intestine and spleen; and in those infected with CL
strain, parasites were found in similar amounts in the heart and
liver. In C57BL/6 mice infected with the G strain, T. cruzi DNA
was found exclusively in the intestine; and in mice infected with
the CL strain, there was parasite DNA in the spleen (Figure 1C).
Quantification of Cytokines and
Chemokines Levels in Serum
At 2 dpi, BALB/c mice infected with both G and CL strains
presented increased concentrations of IL-1α (Figure 3A), IL-5
(Figure 3B), and TGF-β (Figure 3C), IL-9 level was also
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FIGURE 5 | Alterations in Th2 and anti-inflammatory cytokine levels at 8 dpi. At 8 dpi, the levels of the Th2 cytokines IL- 4 (A), IL-5 (B), and IL-6 (C), as well as those
of IL-9 (D) and anti-inflammatory cytokines IL-10 (E) and TGF-β (F) were quantified in the serum from C57BL/6 and BALB/c uninfected mice or those infected with
G or CL strains and were found to be different. The data are presented as box plots, and ∗ indicates a significant difference (p < 0.05) between the infected and
uninfected mice [control (–)].
FIGURE 6 | Altered concentrations of serum chemokines in infected mice at 8 dpi. Serum samples were obtained from healthy C57BL/6 and BALB/c mice and from
those infected with G or CL strains at 8 dpi for the quantification of chemokines levels. The concentrations of CCL-2 (A), CCL-3 (B), CCL-4 (C), CCL-5 (D), CCL-11
(E), CXCL-1 (F), CXCL-9 (G), and CXCL-10 (H) were measured and differed from those of the control. The data are summarized as box plots, and ∗ indicates a
significant difference (p < 0.05) between the infected and uninfected mice [control (–)].
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FIGURE 7 | Altered levels of cytokines in infected mice at 90 dpi. The concentrations of TNF-α (A), IL-1β (B), IL-2 (C), IL-4 (D), IL-5 (E), IL-10 (F), and IL-17 (G) were
quantified in the serum from C57BL/6 and BALB/c uninfected mice and from those infected with G or CL strains at 90 dpi, and their concentrations were found to
be different from those of the control. The data are represented as box plots, and ∗ indicates a significant difference (p < 0.05) between the infected and uninfected
mice [control (–)].
increased, but only in those infected with G strain (Figure 3D).
At this time point, no variation in cytokines in C57BL/6 mice
compared to control group were found, except for INF-γ, which
was increased in CL-infected animals (Figure 3E). Although not
statistically significant, we observed an increase in the level of this
cytokine in BALB/c mice infected with CL strain.
At 8 dpi, concentrations of several cytokines and chemokines
were increased in both mice lineages infected with T. cruzi
G and CL strains (Figures 4–6). TNF-α, INF-γ, IL-1β, and
IL-2, Th1 cytokines, which are related to host resistance and
protection, were increased in almost all experimental groups
(Figure 4). IL-1β and IL-2 concentrations in C57BL/6 mice
infected with CL and G strains, respectively, did not show
significant difference when compared to those of healthy mice but
were present in slightly higher amounts (IL-1β: uninfected mice
33.54 ± 3.21 pg/mL, C57BL/6 + CL strain 44.07 ± 4.35 pg/mL;
IL-2: uninfected mice 2.86 ± 0.86 pg/mL, C57BL/6 + G strain
4.55 ± 1.89 pg/mL). IL-4, IL-5, and IL-6, which are Th2-related
cytokines, were also quantified; IL-4 concentration changed
only in CL-infected BALB/c mice (Figure 5A), while serum
IL-5 and IL-6 levels increased in BALB/c and C57BL/6 mice
infected with both strains (Figures 5B,C). The proinflammatory
cytokine IL-9 was increased only in BALB/c mice independent
of parasite strain (Figure 5D). Regarding to anti-inflammatory
cytokines, IL-10 concentration was increased in all mice infected
with any parasite strain (Figure 5E), while level of TGF-β
was increased only in BALB/c infected mice (Figure 5F).
Additionally, serum concentrations of CCL-2, CCL-3, CCL-4,
CCL-5, CCL-11, CXCL-1, CXCL-9, and CXCL-10 chemokines
were increased in both BALB/c and C57BL/6 infected with G and
CL strains (Figure 6), although level of CXCL-1 in G-infected
C57BL/6 mice was not significantly different from that of the
non-infected group. In general, at this time point, all animals
responded to infection with the release of cytokines, regardless
of mouse lineage or T. cruzi strain, which is expected since in all
groups the parasites were distributed in different tissues.
Interesting differences were observed between groups in
chronic phase at 90 dpi. The levels of several cytokines were
increased in C57BL/6 mice serum independent of T. cruzi strain,
such as TNF-α, IL1-β, IL-4, IL-5, CCL-5, CCL-11, and CXCL-9
(Figures 7, 8); the levels of IL-10 and IL-17 were only increased
with G-strain infection (Figures 7F,G), and the levels of IL-2
and CCL-3 were only increased in mice infected with the CL
strain (Figures 7C, 8A). On the other hand, only the IL-4
cytokine concentration was altered in BALB/c mice infected with
each T. cruzi strain (Figure 7D), and in those infected with
the CL strain there was an increase in the quantity of CXCL-9
(Figure 8D). All cytokine levels were measured in all time points,
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FIGURE 8 | Altered levels of serum chemokines at 90 dpi. Box plots represent the concentrations of CCL-3 (A), CCL-5 (B), CCL-11 (C), and CXCL-9 (D), which
were quantified in the serum from C57BL/6 and BALB/c uninfected mice or those infected with G or CL strains, and the concentrations differed from those of the
control at 90 dpi. ∗ indicates a significant difference (p < 0.05) between the infected and uninfected mice [control (–)].
but those that did not differ from the levels in the control groups
are not shown.
DISCUSSION
Chagas’ disease has acute and chronic phases. In the chronic
phase, patients may be asymptomatic or exhibit cardiomyopathy,
dysfunction in the digestive tract or alterations in the nervous
system (Taniwaki et al., 2005; Rassi et al., 2010). The host immune
system plays key roles during entire infection course. In acute
phase, it acts to control the infection and parasite spread, while
in chronic phase, different responses are related to manifestation
or absence of symptoms (Boscardin et al., 2010; Basso, 2013).
There are two main hypotheses concerning the primary causes
of the chronic manifestation: one hypothesis is related to a
host autoimmune response and the other supposes that the
inflammatory response is sustained by the persistence of parasites
in tissues (Gutierrez et al., 2009; Cunha-Neto et al., 2011). Thus,
considering the importance of both parasite and host factors for
the disease progress, we used two host lineages infected with
distinct T. cruzi strains to evaluate aspects of acute and chronic
phases.
When results from quantification of parasite loads and
concentrations of serum cytokines are collectively reviewed
(Figure 9), it is reasonable to conclude that, although parasite
tropism was influenced by strain, the release of host cytokines
seemed to be related mainly to the mouse lineage. While at 8 dpi,
parasites were spread through the host tissues, and all animals
showed increased levels of cytokines, earlier, at 2 dpi, infected
BALB/c mice showed early release of some cytokines, which did
not occur in C57BL/6 mice. In chronic phase (90 dpi), although
all animals were efficient in controlling parasite spread, C57BL/6
mice had higher amounts of serum cytokines, independent of
T. cruzi strain.
Detailed analysis of the acute phase initial time point (2 dpi)
demonstrated that differences in infectivity of parasite strains
were relevant for an early infection establishment, since CL
strain was detected within the organs of infected mice at 2 dpi.
In fact, strain related characteristics may influence the disease
development (reviewed by Dutra et al., 2014). Interestingly, at
this time point, IFN-γ was detectable in animals infected with
CL parasites. As an important cytokine for the activation of
innate response and parasite destruction (Torrico et al., 1991;
Holscher et al., 1998), increased IFN-γ expression may be a
simple response to high parasite load. However, other cytokines
were increased only in BALB/c mice, unrelated to the parasite
strain. A study with the same mice lineage investigated why
in vitro high infective G strain amastigotes fail to establish in vivo
parasitemia, and the authors concluded that an early response of
inflammatory cytokines such as IL-12 and INF-γ were important
in controlling the infection (Rodrigues et al., 2012). Although the
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FIGURE 9 | Summary of the data from the quantification of serum cytokines and parasite loads. The results of the quantification of serum cytokines levels and
parasite loads are summarized in parallel at each time point. The cytokines and chemokines were included when the concentrations were significantly different from
those of the uninfected mice. Bold fonts and asterisks highlight organs with the highest parasite quantities at each time point, while strikethrough gray fonts are used
when T. cruzi DNA was not detectable. The data observed together suggests that while there are differences in T. cruzi tropism due to parasite strains, the release of
cytokines seems to depend primarily on the host background.
work of Rodrigues did not evaluate the alterations in IL-1β, IL-5,
TGF-β, and IL-9 cytokine levels, it is possible to infer that early
release of cytokines is relevant to BALB/c mice response and it
is related to host lineage, since this pattern was not observed in
C57BL/6 mice.
In experimental studies, resistance to T. cruzi infection was
related to Th1 cytokine profile, such as IFN- γ, TNF-α, and IL-1
(Silva et al., 1995; Sanoja et al., 2013), and Th2, which is required
for tissue protection (Basso, 2013). In our study, virtually all
animals showed increased levels of TNF-α, INF-γ, IL-1β, IL-2,
IL-5, and IL-6 at 8 dpi. The importance of these cytokines
in the response to infection may be seen in recent studies in
which the inhibition of IL-18 or 5-lipoxygenase improved the
resistance of mice to parasites in acute phase, with an increase
in levels of cytokines such as IL-12, INF-γ, IL-1β, and IL-6 and a
decrease in the level of IL-10 (Canavaci et al., 2014; Esper et al.,
2014). Similar to TGF-β, IL-10 is an anti-inflammatory cytokine
related to infection susceptibility (Silva et al., 1991; Canavaci
et al., 2014; Esper et al., 2014). Our results revealed that all
animals had increased levels of IL-10 in their serum, and only
BALB/c mice presented an increased release of TGF-β. These
cytokines are important in the control of immune response, for
instance, a study described that deregulation of pro-and anti-
inflammatory cytokines was implicated in disease lethality during
acute phase. Susceptible mice in acute phase had even greater
release of TNF-α than the resistant lineage, but a lower release of
IL-10 (Roggero et al., 2002). Thus, the fact that all mice showed
increased IL-10 levels but only BALB/c showed increased TGF-β
levels at this infection time point may imply that these mice
presented a more regulated and efficient response than those of
C57BL/6 lineage. Regarding the chemokines, diverse studies in
humans and mice have indicated that CXCL1, CXCL9, CXCL10,
CCL2, CCL3, CCL4, and CCL5 are important in controlling the
infection during the acute phase (Aliberti et al., 1999; Hardison
et al., 2006; Cunha-Neto et al., 2009; Paiva et al., 2009), and the
levels of virtually all of them were increased in both BALB/c
and C57BL/6 mice. In addition, both mouse lineages had an
increase in the level of CCL11 at 8 dpi, and although there are
not many studies addressing the relationship of this chemokine
to T. cruzi infection response, it has been described that CCL11
mRNA expression is increased in cardiomyocytes infected with
the parasite (Udoko et al., 2016), and this chemokine has been
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related to myocardial fibrosis (Zweifel et al., 2010). At this stage,
no relation was observed between the host response and the
spread of the parasite; in all cases, high parasite loads and the
presence of nests were observed in different tissues, with only
small differences in tropism, such as in the heart, where the
parasite load was higher in BALB/c mice, especially those infected
with the G strain. Therefore, it is noteworthy to mention that in
a recent study, CL strain was almost undetected in the heart of
orally infected mice (Rodrigues et al., 2016).
Regarding to the chronic phase, several studies in both
humans and experimental models reported that the presence
of an undetermined or symptomatic chronic phase is directly
related to inflammatory response and the type of cytokines
present in the subject. Chronic chagasic patients display
predominantly cytokines such as TNF-α, INF-γ, and IL-6, and
asymptomatic patients have higher amounts of IL-4, IL-10,
IL-13, and TGF-β (Gomes et al., 2003; Poveda et al., 2014;
Sousa et al., 2014). The present study demonstrated that at
90 dpi, BALB/c mice had alterations only in levels of IL-
4 and CXCL-9 (in those infected with G strain). CXCL9 is
important in the development of chronic disease (Nogueira
et al., 2012), but no essential role in tissue inflammation has
been observed for it (Hardison et al., 2006). Regarding to IL-4,
knockout mice displayed reduced acute phase parasitemia but
showed subsequent increases in inflammation compared to non-
depleted mice (Soares et al., 2001), indicating that this cytokine
is necessary for tissue protection in the chronic phase. On the
other hand, we observed that in all C57BL/6 mice, levels of several
cytokines and serum chemokines increased at this infection time
point (TNF-α, IL-1β, IL-4, IL-5, CCL-5, CCL-11, and CXCL-9, in
addition to IL-2, IL-10, IL-17 and CCL-3, depending on the strain
of T. cruzi), indicating a lack of immune response control similar
to that occurring in the chronic phase (Perez et al., 2011; Sousa
et al., 2014). TNF-α is particularly increased in chronic patients
and is considered an important indicator of cardiomyopathy
(Talvani et al., 2004; Requena-Mendez et al., 2013; Keating et al.,
2015). Interestingly, despite different responses observed between
BALB/c and C57BL/6 mice, qPCR results showed that both
were efficient to control the infection. These results indicate that
persistence of parasites in the organs is not precisely related to
inflammatory response. Supporting our findings, a study showed
that mice infected with CL Brener had cardiac fibrosis and
myocarditis, even without the presence of parasites in heart
(Lewis et al., 2014). On the other hand, it is possible that C57BL/6
mice were more efficient in eliminating the parasite, since parasite
amount in the organs at 90 dpi were smaller in C57BL/6 mice
than in BALB/c mice (undetectable in a few cases). Nevertheless,
these mice were inefficient at controlling their immune responses,
which may have led to the observed cytokine profiles. This
possibility is reinforced by the fact that in the acute phase, there
were smaller amounts of anti-inflammatory cytokines in C57BL/6
mice than in BALB/c mice.
In experimental infection characteristics of T. cruzi infection
differ according to mouse lineage and parasite strain (Gonçalves
da Costa et al., 2002; Sanoja et al., 2013). The results presented
here using isogenic BALB/c and C57BL/6 mice infected with
G (Tc I, less infective) or CL (Tc VI, more infective) strains
suggest that in these models differences in the immune response
during disease progression is likely related to host characteristics
and not to strain infectivity. Accordingly, studies in literature
support the notion on the relevance of host genetic background
in the manifestation of symptoms in chronic Chagas’ disease
(Frade et al., 2013; Luz et al., 2016). Additionally, the exacerbated
inflammatory response observed in chronic phase of the disease
may be the result of a deficiency in controlling the host response
(that initially leads to parasite suppression) but not necessarily
due to parasite persistence in different host tissues.
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